Evidence-based guidelines for the investigation and medical treatment of recurrent miscarriage [1]

Human Reproduction

Volumn 22, Issue 1, 2007, Pages 309-

  Bohlmann, Michael K ^a   Luedders, D W ^b   von Wolff, M ^c  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^b UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^c UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 5 LEIDEN; HEPARIN;

BIRTH RATE; DRUG MECHANISM; EVIDENCE BASED MEDICINE; FIRST TRIMESTER PREGNANCY; GENE MUTATION; HETEROZYGOSITY; HIGH RISK PATIENT; HUMAN; LETTER; PRACTICE GUIDELINE; PREGNANCY OUTCOME; RISK FACTOR; RISK REDUCTION; SECOND TRIMESTER PREGNANCY; SPONTANEOUS ABORTION; THROMBOPHILIA; TROPHOBLAST; VEIN THROMBOSIS;

EID: 33845656967     PISSN: 02681161     EISSN: 14602350     Source Type: Journal    
DOI: 10.1093/humrep/del349     Document Type: Letter

References (7)

1. Carp H, Dolitzky M and Inbal A (2003) Thromboprophylaxis improves the live birth rate in women with consecutive recurrent miscarriages and hereditary thrombophilia. J Thromb Haemost 1,433-438.
2. Carp H, Dolitzky M, Tur-Kaspa I and Inbal A (2002) Hereditary thrombophilias are not associated with a decreased live birth rate in women with recurrent miscarriage. Fertil Steril 78,58-62.
3. van Dunne FM, Doggen CJ, Heemskerk M, Rosendaal FR and Helmerhorst FM (2005) Factor V Leiden mutation in relation to fecundity and miscarriage in women with venous thrombosis. Hum Reprod 20,802-806.
4. Hills FA, Abrahams VM, Gonzalez-Timon B, Francis J, Cloke B, Hinkson L, Rai R, Mor G, Regan L, Sullivan M et al. (2006) Heparin prevents programmed cell death in human trophoblast. Mol Hum Reprod 12,237-243.
5. Jauniaux E, Farquharson RG, Christiansen OB and Exalto N (2006) Evidence-based guidelines for the investigation and medical treatment of recurrent miscarriage. Hum Reprod May 17; [Epub Ahead of Print]
6. Rey E, Kahn SR, David M and Shrier I (2003) Thrombophilic disorders and fetal loss: A meta-analysis. Lancet 361,901-908.
7. Robertson L, Wu O, Langhorne P, Twaddle S, Clark P, Lowe GD, Walker ID, Greaves M, Brenkel I, Regan L et al. (2006) The Thrombosis: Risk and Economic Assessment of Thrombophila Screening (TREATS) Study. Thrombophilia in pregnancy: A systematic review. Br J Haematol 132,171-196.